Literature DB >> 32381379

Saliva samples as an alternative for novel coronavirus (COVID-19) diagnosis.

Javad Alizargar1, Milad Etemadi Sh2, Mehdi Aghamohammadi3, Shahrokh Hatefi4.   

Abstract

Entities:  

Mesh:

Year:  2020        PMID: 32381379      PMCID: PMC7252064          DOI: 10.1016/j.jfma.2020.04.030

Source DB:  PubMed          Journal:  J Formos Med Assoc        ISSN: 0929-6646            Impact factor:   3.871


× No keyword cloud information.
Cheng et al. reported the first case of novel coronavirus pneumonia (COVID-19) in Taiwan. They mentioned that oropharyngeal and sputum swabs were used for diagnosis of this viral infection. Later they mentioned that they used urine and stool samples to check if the patient had recovered. Currently the diagnosis of COVID-19 is made based on the throat swabs. This sampling method is invasive and may cause sneezing in the patient and also cause some danger for the test takers. Furthermore, throat swab might be uncomfortable for the patient as it might cause bleeding. All cells that express surface receptor angiotensin-converting enzyme II (ACE2) receptor are susceptible to COVID-19. Salivary gland express ACE2 receptor, so potentially can be a target for COVID-193. Although the reports about the accuracy of the screening properties of saliva for COVID-19 is still scarce, there have been some reports in which saliva has been considered as an alternative for diagnosis of COVID-19.4, 5, 6, 7 Williams et al., investigated the feasibility of using saliva specimens for detecting COVID-19 in the patients. In their study, 622 patients underwent COVID-19 test by using patient's saliva specimens and nasopharyngeal swabs at the same time for comparison. Among all patients, 39 patients had positive tests based on nasopharyngeal samples. Interestingly COVID-19 was detected in the saliva of 33 patients, leaving behind only 2 cases undetected. Keeping in mind that the nasopharyngeal swabs are also not very sensitive for the detection of COVID-19, the accuracy of saliva is comparable with the conventional nasopharyngeal sampling method. Use of saliva samples, which are safer and more convenient for the patient and test taker can be considered an alternative for diagnosis of COVID-19.

Declaration of Competing Interest

The authors have no conflicts of interest relevant to this article.
  9 in total

1.  Detection of SARS-CoV-2 in Different Types of Clinical Specimens.

Authors:  Wenling Wang; Yanli Xu; Ruqin Gao; Roujian Lu; Kai Han; Guizhen Wu; Wenjie Tan
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

2.  Saliva as a Noninvasive Specimen for Detection of SARS-CoV-2.

Authors:  Eloise Williams; Katherine Bond; Bowen Zhang; Mark Putland; Deborah A Williamson
Journal:  J Clin Microbiol       Date:  2020-07-23       Impact factor: 5.948

3.  Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Wai-Shing Leung; Anthony Raymond Tam; Tak-Chiu Wu; David Christopher Lung; Cyril Chik-Yan Yip; Jian-Piao Cai; Jacky Man-Chun Chan; Thomas Shiu-Hong Chik; Daphne Pui-Ling Lau; Chris Yau-Chung Choi; Lin-Lei Chen; Wan-Mui Chan; Kwok-Hung Chan; Jonathan Daniel Ip; Anthony Chin-Ki Ng; Rosana Wing-Shan Poon; Cui-Ting Luo; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Ivan Fan-Ngai Hung; Zhiwei Chen; Honglin Chen; Kwok-Yung Yuen
Journal:  Lancet Infect Dis       Date:  2020-03-23       Impact factor: 25.071

4.  Detection of SARS-CoV-2 in saliva and characterization of oral symptoms in COVID-19 patients.

Authors:  Lili Chen; Jiajia Zhao; Jinfeng Peng; Xiaoshuang Li; Xuliang Deng; Zhi Geng; Zhenyu Shen; Fengyuan Guo; Qianwen Zhang; Yang Jin; Lin Wang; Songlin Wang
Journal:  Cell Prolif       Date:  2020-10-19       Impact factor: 6.831

5.  Molecular and serological investigation of 2019-nCoV infected patients: implication of multiple shedding routes.

Authors:  Wei Zhang; Rong-Hui Du; Bei Li; Xiao-Shuang Zheng; Xing-Lou Yang; Ben Hu; Yan-Yi Wang; Geng-Fu Xiao; Bing Yan; Zheng-Li Shi; Peng Zhou
Journal:  Emerg Microbes Infect       Date:  2020-02-17       Impact factor: 7.163

6.  Consistent Detection of 2019 Novel Coronavirus in Saliva.

Authors:  Kelvin Kai-Wang To; Owen Tak-Yin Tsang; Cyril Chik-Yan Yip; Kwok-Hung Chan; Tak-Chiu Wu; Jacky Man-Chun Chan; Wai-Shing Leung; Thomas Shiu-Hong Chik; Chris Yau-Chung Choi; Darshana H Kandamby; David Christopher Lung; Anthony Raymond Tam; Rosana Wing-Shan Poon; Agnes Yim-Fong Fung; Ivan Fan-Ngai Hung; Vincent Chi-Chung Cheng; Jasper Fuk-Woo Chan; Kwok-Yung Yuen
Journal:  Clin Infect Dis       Date:  2020-07-28       Impact factor: 9.079

Review 7.  Saliva: potential diagnostic value and transmission of 2019-nCoV.

Authors:  Ruoshi Xu; Bomiao Cui; Xiaobo Duan; Ping Zhang; Xuedong Zhou; Quan Yuan
Journal:  Int J Oral Sci       Date:  2020-04-17       Impact factor: 6.344

8.  Author reply to Letters to the Editor "COVID-19 pneumonia in Taiwan".

Authors:  Shao-Chung Cheng; Yu-Long Fan Chiang; Chia-Husn Huang; Yuan-Nian Hsu
Journal:  J Formos Med Assoc       Date:  2020-04-02       Impact factor: 3.282

9.  First case of Coronavirus Disease 2019 (COVID-19) pneumonia in Taiwan.

Authors:  Shao-Chung Cheng; Yuan-Chia Chang; Yu-Long Fan Chiang; Yu-Chan Chien; Mingte Cheng; Chin-Hua Yang; Chia-Husn Huang; Yuan-Nian Hsu
Journal:  J Formos Med Assoc       Date:  2020-02-26       Impact factor: 3.282

  9 in total
  7 in total

1.  Recommendations for Dental Care during COVID-19 Pandemic.

Authors:  Katarzyna Gurzawska-Comis; Kathrin Becker; Giulia Brunello; Agata Gurzawska; Frank Schwarz
Journal:  J Clin Med       Date:  2020-06-12       Impact factor: 4.241

2.  Antigen tests for COVID-19.

Authors:  Yuta Kyosei; Sou Yamura; Mayuri Namba; Teruki Yoshimura; Satoshi Watabe; Etsuro Ito
Journal:  Biophys Physicobiol       Date:  2021-02-10

3.  Pre-analytical sample stabilization by different sampling devices for PCR-based COVID-19 diagnostics.

Authors:  Melina Hardt; Esther Föderl-Höbenreich; Stephanie Freydl; Antonio Kouros; Martina Loibner; Kurt Zatloukal
Journal:  N Biotechnol       Date:  2022-04-08       Impact factor: 6.490

4.  Sample collection and transport strategies to enhance yield, accessibility, and biosafety of COVID-19 RT-PCR testing.

Authors:  Padmapriya Banada; David Elson; Naranjargal Daivaa; Claire Park; Samuel Desind; Ibsen Montalvan; Robert Kwiatkowski; Soumitesh Chakravorty; David Alland; Yingda L Xie
Journal:  J Med Microbiol       Date:  2021-09       Impact factor: 2.472

5.  Clinical trial and detection of SARS-CoV-2 by a commercial breath analysis test based on Terahertz technology.

Authors:  Meila Bastos De Almeida; Regina Aharonov-Nadborny; Eran Gabbai; Ana Paula Palka; Leticia Schiavo; Elis Esmanhoto; Irina Riediger; Jaime Rocha; Ariel Margulis; Marcelo Loureiro; Christina Pettan-Brewer; Louise Bach Kmetiuk; Ivan Roque De Barros-Filho; Alexander Welker Biondo
Journal:  PLoS One       Date:  2022-09-20       Impact factor: 3.752

Review 6.  The Current Status and Challenges in the Development of Vaccines and Drugs against Severe Acute Respiratory Syndrome-Corona Virus-2 (SARS-CoV-2).

Authors:  Narasimha M Beeraka; SubbaRao V Tulimilli; Medha Karnik; Surya P Sadhu; Rajeswara Rao Pragada; Gjumrakch Aliev; SubbaRao V Madhunapantula
Journal:  Biomed Res Int       Date:  2021-06-01       Impact factor: 3.411

Review 7.  SARS-CoV-2 pandemic: a review of molecular diagnostic tools including sample collection and commercial response with associated advantages and limitations.

Authors:  Harikrishnan Jayamohan; Christopher J Lambert; Himanshu J Sant; Alexander Jafek; Dhruv Patel; Haidong Feng; Michael Beeman; Tawsif Mahmood; Ugochukwu Nze; Bruce K Gale
Journal:  Anal Bioanal Chem       Date:  2020-10-18       Impact factor: 4.142

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.